Group One Trading
ORIC icon

Group One Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Group One Trading’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,000
Closed -$108K – 8877
2025
Q3 		$108K Buy
+9,000
New +$94.7K ﹤0.01% 5271
2025
Q2 		– Sell
-900
Closed -$5.02K – 8461
2025
Q1 		$5.02K Buy
+900
New +$7.87K ﹤0.01% 6644
2024
Q4 		– Sell
-100
Closed -$1.02K – 7772
2024
Q3 		$1.02K Buy
+100
New +$989 ﹤0.01% 6290

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Group One Trading's ORIC Position: Q1 2026 in Review

Group One Trading opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 100 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #7168 among its holdings. This is a return to the name: Group One Trading previously reported a position in ORIC as recently as Q2 2025.

Group One Trading first reported a position in ORIC in Q2 2022 and has held it in 7 quarters since. The position peaked at $32.6K in Q2 2023. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Group One Trading held 100 shares of Oric Pharmaceuticals worth $1.27K as of Q1 2026.
  • Oric Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7168 holding.
  • Group One Trading first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 7 quarters since.
  • Group One Trading's Oric Pharmaceuticals position peaked at $32.6K in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.